F
$ Value
$32K
Shares
1,614
Price
$20
Filed
Mar 3
Insider
Name
Rasul Reazur
Title
EVP,Group Pres,Healthcare
CIK
0001967379
Roles
Officer
Transaction Details
Transaction Date
2026-03-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
138,231
Footnotes
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.
Filing Info
Rasul Reazur's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | BAX | F | $224K |
| 2026-03-02 | BAX | F | $32K |
| 2026-02-09 | BAX | A | $0 |
| 2026-02-09 | BAX | F | $125K |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |